These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28815076)

  • 1. Definitive chemoradiotherapy.
    Stahl M; Budach W
    J Thorac Dis; 2017 Jul; 9(Suppl 8):S792-S798. PubMed ID: 28815076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoradiotherapy in tumours of the oesophagus and gastro-oesophageal junction.
    Hulshof MC; van Laarhoven HW
    Best Pract Res Clin Gastroenterol; 2016 Aug; 30(4):551-63. PubMed ID: 27644904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinoma.
    Reid TD; Davies IL; Mason J; Roberts SA; Crosby TD; Lewis WG
    Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):617-24. PubMed ID: 22386923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after neoadjuvant chemoradiotherapy and oesophagectomy versus definitive chemoradiotherapy for patients with oesophageal squamous cell carcinoma.
    Wang BY; Wu SC; Chen HC; Hung WH; Lin CH; Huang CL; Chen HS
    Br J Surg; 2019 Feb; 106(3):255-262. PubMed ID: 30395362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
    Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; Muller K; van Laarhoven HW; Hulshof MC
    Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27766725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes for Esophageal Squamous Cell Carcinoma Treated with Curative Intent in a Western Cohort: Should Multimodal Therapy Be the Gold Standard?
    Sheil F; Donohoe CL; King S; O'Toole D; Cunningham M; Cuffe S; Ravi N; Reynolds JV
    World J Surg; 2018 May; 42(5):1485-1495. PubMed ID: 29075858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall survival after definitive chemoradiotherapy for patients with esophageal cancer: a retrospective cohort study.
    van der Zijden CJ; Bouwman A; Mostert B; Nuyttens JJME; van der Sluis PC; Spaander MCW; Mens JWM; Homs MYV; van Doorn L; Wijnhoven BPL; Lagarde SM
    Dis Esophagus; 2024 Jun; ():. PubMed ID: 38836354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.
    Sugawara K; Yagi K; Okumura Y; Nishida M; Aikou S; Yamashita H; Yamashita H; Seto Y
    Int J Clin Oncol; 2020 Apr; 25(4):552-560. PubMed ID: 31828451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eight cases of salvage pulmonary resection for residual disease or isolated local recurrence detected after definitive chemoradiotherapy for N2 Stage-IIIA lung cancer.
    Sawada S; Suehisa H; Ueno T; Yamashita M
    Asian J Surg; 2017 Apr; 40(2):95-99. PubMed ID: 26362070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does cervical lymph node recurrence after oesophagectomy or definitive chemoradiotherapy for thoracic oesophageal squamous cell carcinoma benefit from salvage treatment?
    Yuan X; Lv J; Dong H; Wang J
    Interact Cardiovasc Thorac Surg; 2017 May; 24(5):792-795. PubMed ID: 28453803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.
    Kumagai K; Mariosa D; Tsai JA; Nilsson M; Ye W; Lundell L; Rouvelas I
    Dis Esophagus; 2016 Oct; 29(7):734-739. PubMed ID: 26316181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity score analysis of oesophageal cancer treatment with surgery or definitive chemoradiotherapy.
    Karran A; Blake P; Chan D; Reid TD; Davies IL; Kelly M; Roberts SA; Crosby T; Lewis WG
    Br J Surg; 2014 Apr; 101(5):502-10. PubMed ID: 24615406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus.
    Münch S; Pigorsch SU; Devečka M; Dapper H; Feith M; Friess H; Weichert W; Jesinghaus M; Braren R; Combs SE; Habermehl D
    Radiat Oncol; 2019 Apr; 14(1):66. PubMed ID: 30992022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis on salvage surgery as a potentially curative procedure in patients with isolated local recurrent or persistent esophageal cancer after chemoradiotherapy.
    Faiz Z; Dijksterhuis WPM; Burgerhof JGM; Muijs CT; Mul VEM; Wijnhoven BPL; Smit JK; Plukker JTM
    Eur J Surg Oncol; 2019 Jun; 45(6):931-940. PubMed ID: 30447937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome after resection for recurrent oesophageal cancer.
    Kato F; Monma S; Koyanagi K; Kanamori J; Daiko H; Igaki H; Tachimori Y
    J Thorac Dis; 2018 May; 10(5):2691-2699. PubMed ID: 29997931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthermia combined with chemotherapy for patients with residual or recurrent oesophageal cancer after definitive chemoradiotherapy.
    Nishimura S; Saeki H; Nakanoko T; Kasagi Y; Tsuda Y; Zaitsu Y; Ando K; Nakashima Y; Imamura YU; Ohgaki K; Oki E; Ohga S; Nakamura K; Morita M; Maehara Y
    Anticancer Res; 2015 Apr; 35(4):2299-303. PubMed ID: 25862892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after definitive (chemo)radiotherapy in esophageal cancer patients: a population-based study in the north-East Netherlands.
    Smit JK; Muijs CT; Burgerhof JG; Paardekooper G; Timmer PR; Muller K; Woutersen D; Mul VE; Beukema JC; Hospers GA; van Dijk BA; Langendijk JA; Plukker JT
    Ann Surg Oncol; 2013 Jun; 20(6):1985-92. PubMed ID: 23274534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
    Yap WK; Chang YC; Hsieh CH; Chao YK; Chen CC; Shih MC; Hung TM
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):689-698. PubMed ID: 29188300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of definitive chemoradiation in patients with non-metastatic oesophageal cancer.
    Jeene PM; van Laarhoven HWM; Hulshof MCCM
    Best Pract Res Clin Gastroenterol; 2018; 36-37():53-59. PubMed ID: 30551857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current optimal multimodality treatments for oesophageal squamous-cell carcinoma: A systematic review and meta-analysis.
    Li F; Ding N; Zhao Y; Yuan L; Mao Y
    Int J Surg; 2018 Dec; 60():88-100. PubMed ID: 30389537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.